The receptor for advanced glycation endproducts (RAGE) does not contribute to pathology in a mouse mesenteric ischemia/reperfusion-induced injury model
The receptor for advanced glycation endproducts (RAGE) can engage a diverse class of ligands and contribute to the immune and inflammatory response to infection and injury. It is known to be a pathogenic receptor in many inflammatory diseases, including ischemia/reperfusion (IR) injuries in several...
Main Authors: | Mike C.L. Wu, Timothy D. Gilmour, Susanna eMantovani, Trent M. Woodruff |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00614/full |
Similar Items
-
Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE)
by: Lindsey R. Drake, et al.
Published: (2020-10-01) -
HMGB1/RAGE axis in tumor development: unraveling its significance
by: Anqi Fan, et al.
Published: (2024-03-01) -
Electroacupuncture inhibits the expression of HMGB1/RAGE and alleviates injury to the primary motor cortex in rats with cerebral ischemia
by: Nie Zeyin, et al.
Published: (2023-10-01) -
Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression
by: Ali H. El-Far, et al.
Published: (2020-05-01) -
The Receptor for Advanced Glycation Endproducts (RAGE) Contributes to Severe Inflammatory Liver Injury in Mice
by: Toni Weinhage, et al.
Published: (2020-06-01)